• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ALK-Abello A/S

+ Add to Watchlist

4AJ:GR

98.033 EUR 0.573 0.59%

As of 02:09:15 ET on 09/16/2014.

Snapshot for ALK-Abello A/S (4AJ)

Open: 98.040 Day's Range: 98.020 - 98.040 Volume: 0
Previous Close: 97.460 52wk Range: 63.679 - 115.860 1-Yr Rtn: +48.27%

Stock Chart for 4AJ

No chart data available.
  • 4AJ:GR 98.033
  • 1D
  • 1M
  • 1Y
97.460
Interactive 4AJ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4AJ

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 36.5967
Relative P/E vs. DAX -
Earnings Per Share (DKK) (ttm) -
Est. EPS (DKK) (12/2014) 19.9440
Est. PEG Ratio -
Market Cap (M EUR) 989.02
Shares Outstanding (M) 9.21
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.68%
Cash Dividend (DKK) 5.0000
Dividend Ex-Date 03/13/2014
5 Year Dividend Growth -0.04%
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4AJ

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for 4AJ

Alk-Abello A/S produces pharmaceuticals for allergy vaccination. The Company is an international group with subsidiaries and associated companies worldwide.

Jens BagerPresident/CEOSoren NiegelExec VP:Commercial Operations
Flemming PedersenExec VP:Finance & IT/CFOHenrik JacobiExec VP:Research & Dev
More Company Profile & Key Executives for 4AJ

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil